跳到主要內容

Ballal Rahul D. 的 Form 4 申報

Enliven Therapeutics, Inc.(ELVN),2024/4/12 申報

申報編號
0001415889-24-010777
申報時間
2024/4/12
交易日
2024/4/10-4/11
申報延遲
2 天
10b5-1 計畫
有勾選

這份申報列了 7 筆非衍生性交易、3 筆衍生性交易。公開市場賣出合計 $156.5 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Ballal Rahul D.CIK 0001805097董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2024/4/10Common StockM行使選擇權取得+13,600$12.60+$171,36035,941直接
2024/4/10Common StockS賣出處分−13,600$21.01F2−$285,73622,341直接
2024/4/11Common StockM行使選擇權取得+48,820$12.60+$615,13271,161直接
2024/4/11Common StockM行使選擇權取得+4,580$19.68+$90,134.475,741直接
2024/4/11Common StockS賣出處分−30,300$23.14F3−$701,14245,441直接
2024/4/11Common StockS賣出處分−20,032$25.00F4−$500,80025,409直接
2024/4/11Common StockS賣出處分−3,068$25.21F5−$77,344.2822,341直接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2024/4/10Common StockM行使選擇權處分−13,600$0.00$048,820直接
2024/4/11Common StockM行使選擇權處分−48,820$0.00$00直接
2024/4/11Common StockM行使選擇權處分−4,580$0.00$075,742直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

This transaction was executed in multiple trades at prices ranging from $21.00 to $21.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

F3

This transaction was executed in multiple trades at prices ranging from $23.00 to $23.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

F4

This transaction was executed in multiple trades at prices ranging from $24.015 to $25.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

F5

This transaction was executed in multiple trades at prices ranging from $25.02 to $25.485. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)